PRA Health Sciences, Inc. Operating Cash Flow
PRA Health Sciences, Inc. reported Operating Cash Flow of $192.21 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-04-29
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was $192.21M, a 217.26% increase year-over-year.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was $160.07M, a 14.66% decline year-over-year.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was $180.64M, a 155.14% increase year-over-year.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was $25.89M.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2020 was $427.18M, a 68.47% increase from fiscal 2019.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2019 was $253.57M, a 23.11% decline from fiscal 2018.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2018 was $329.79M, a 49.63% increase from fiscal 2017.
- PRA Health Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2017 was $220.41M, a 37.71% increase from fiscal 2016.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-03-31 | $192.21M 10-Q · filed 2021-04-29 | $352.28M derived: sum of 2 quarters · filed 2021-04-29 | $532.92M derived: sum of 3 quarters · filed 2021-04-29 | $558.80M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $160.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $340.71M derived: sum of 2 quarters · filed 2021-02-24 | $366.60M derived: sum of 3 quarters · filed 2021-02-24 | $427.18M 10-K · filed 2021-02-24 |
| 2020-09-30 | $180.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $206.52M derived: sum of 2 quarters · filed 2020-11-05 | $267.10M 10-Q · filed 2020-11-05 | $454.68M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | $25.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $86.47M 10-Q · filed 2020-08-07 | $274.04M derived: sum of 3 quarters · filed 2021-04-29 | $344.84M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | $60.58M 10-Q · filed 2021-04-29 | $248.15M derived: sum of 2 quarters · filed 2021-04-29 | $318.95M derived: sum of 3 quarters · filed 2021-04-29 | $273.12M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $187.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $258.37M derived: sum of 2 quarters · filed 2021-02-24 | $212.54M derived: sum of 3 quarters · filed 2021-02-24 | $253.57M 10-K · filed 2021-02-24 |
| 2019-09-30 | $70.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $24.97M derived: sum of 2 quarters · filed 2020-11-05 | $66.00M 10-Q · filed 2020-11-05 | $197.21M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$45.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$4.80M 10-Q · filed 2020-08-07 | $126.41M derived: sum of 3 quarters · filed 2021-02-24 | $237.80M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $41.03M 10-Q · filed 2020-05-01 | $172.24M derived: sum of 2 quarters · filed 2021-02-24 | $283.63M derived: sum of 3 quarters · filed 2021-02-24 | $336.20M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $131.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $242.60M derived: sum of 2 quarters · filed 2021-02-24 | $295.17M derived: sum of 3 quarters · filed 2021-02-24 | $329.79M 10-K · filed 2021-02-24 |
| 2018-09-30 | $111.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $163.96M derived: sum of 2 quarters · filed 2019-10-31 | $198.58M 10-Q · filed 2019-10-31 | $301.16M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $52.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $87.19M 10-Q · filed 2019-08-01 | $189.77M derived: sum of 3 quarters · filed 2020-02-21 | $291.66M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $34.62M 10-Q · filed 2019-05-02 | $137.20M derived: sum of 2 quarters · filed 2020-02-21 | $239.09M derived: sum of 3 quarters · filed 2020-02-21 | $265.82M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $102.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $204.47M derived: sum of 2 quarters · filed 2020-02-21 | $231.20M derived: sum of 3 quarters · filed 2020-02-21 | $220.41M 10-K · filed 2020-02-21 |
| 2017-09-30 | $101.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $128.62M derived: sum of 2 quarters · filed 2018-11-06 | $117.83M 10-Q · filed 2018-11-06 | $211.17M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $26.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $15.94M 10-Q · filed 2018-08-02 | $109.28M derived: sum of 3 quarters · filed 2019-02-28 | $151.93M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$10.80M 10-Q · filed 2018-04-26 | $82.54M derived: sum of 2 quarters · filed 2019-02-28 | $125.20M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | $93.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $136.00M derived: sum of 2 quarters · filed 2019-02-28 | $160.05M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $42.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $66.71M 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | $24.05M 10-Q · filed 2017-08-08 |